NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1%
Tue, 13 Aug

NOVARTIS has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

NOVARTIS Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m1,3811,1041,093-1.0%-20.8%
Other incomeRs m223134109-18.9%-51.1%
TurnoverRs m1,6041,2381,202-2.9%-25.1%
ExpensesRs m1,4169051,14526.5%-19.1%
Gross profitRs m-35199-52-126.2%
DepreciationRs m7932253.8%387.9%
InterestRs m150120.0%-24.2%
Profit before taxRs m16632413-96.0%-92.1%
TaxRs m661295-96.0%-92.1%
Profit after taxRs m1001958-96.0%-92.1%
Gross profit margin%-2.518.0-4.8
Effective tax rate%39.739.739.7
Net profit margin%6.215.80.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 20.8% on a year-on-year (YoY) basis. The expenses were down by 19.1% YoY during the same period.
  • The company's operating profit increased by 48.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 4.8% in 1QFY20 as against 2.5% in 1QFY19.
  • Depreciation charges increased by 387.9% and finance costs declined by 24.2% YoY, respectively.
  • Other income declined by 51.1% YoY during the quarter.
  • Net profit for the quarter declined by 92.1% YoY. Net profit margins during the quarter declined from 6.2% in 1QFY19 to 0.7% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 1.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 26.5% QoQ during the same period.
  • The company's operating profit declined by 126.2% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 4.8% in 1QFY20 as against 18.0% in 4QFY19.
  • Net profit for the quarter declined by 96.0% QoQ, while net profit margins declined from 15.8% in 4QFY19 to 0.7% in 1QFY20.

To see how NOVARTIS has performed over the last eight quarters,please visit here.

NOVARTIS Share Price Performance

Over the last one year,NOVARTIS share price has moved down from Rs 701.9 to Rs 584.0, registering a Loss of Rs 117.9 or around 16.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,744.3 (up 0.4%). Over the last one year it has moved down from 14,332.1 to 12,744.3, a gain of 1,588 points (down 11.1%).

Overall, the S&P BSE SENSEX is down 1.3% over the year.

Current Valuations

At the current price of Rs 584.0, the price to earnings (P/E) ratio of NOVARTIS stands at 460.3 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 26.7 times.

Equitymaster requests your view! Post a comment on "NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1%". Click here!

  

Related Views on News

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Sep 20, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - ADCOCK INGRAM COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS